Director/PDMR Shareholding

CVS Group plc

02 June 2025

 

2 June 2025

CVS Group plc

("CVS" or the "Company")

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 2 June 2025 that David Wilton, Non-executive Chairman of the Company, purchased a total of 1,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, David Wilton's total interest in the Company, including all persons closely associated, is now 10,000 Ordinary Shares, representing 0.014% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                           via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker)                                                      [phone]

Christopher Golden / James Steel / Andrew Clark

   Berenberg (Joint Broker)                                                                                        [phone]

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                                [phone]

Ginny Pulbrook                                                                                                            [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Wilton
2	Reason for the notification
a)	Position/status	PDMR (Chairman)
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	CVS Group plc
b)	LEI	213800J41XDQ2NX48O05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2 pence each GB00B2863827
b)	Nature of the transaction	On-market purchase
c)	Price(s) and volume(s)	Price(s) - pence Volume(s) 1,247.60 1,000
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	2 June 2025
f)	Place of the transaction	London Stock Exchange - AIM (XLON)

 

END